Cas:6629-04-5 N-Cyanoacetylurethane manufacturer & supplier

We serve Chemical Name:N-Cyanoacetylurethane CAS:6629-04-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-Cyanoacetylurethane

Chemical Name:N-Cyanoacetylurethane
CAS.NO:6629-04-5
Synonyms:Carbamic acid, (cyanoacetyl)-, ethyl ester;MFCD00001937;EINECS 229-615-4;N-Cyanoacetylurethane;Carbamic acid, N-(2-cyanoacetyl)-, ethyl ester;Ethyl (cyanoacetyl)carbamate
Molecular Formula:C6H8N2O3
Molecular Weight:156.139
HS Code:2926909090

Physical and Chemical Properties:
Melting point:167-169ºC(lit.)
Boiling point:N/A
Density:1.2±0.1 g/cm3
Index of Refraction:1.452
PSA:79.19000
Exact Mass:156.053497
LogP:-0.65

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like Carbamic acid, (cyanoacetyl)-, ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl (cyanoacetyl)carbamate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Carbamic acid, (cyanoacetyl)-, ethyl ester Use and application,Ethyl (cyanoacetyl)carbamate technical grade,usp/ep/jp grade.


Related News: This not only makes it easier to remove enzyme residues from the desired product, but also ensures valuable high turnover enzymes can be reused multiple times without compromising their activity. 4-(6-amino-purin-3-yl)-2,3-dihydroxy-butyric acid manufacturers Biogen hiked its revenue guidance for the year, saying it expects total sales of $10.65 billion to $10.85 billion this year. That’s up from its previous estimates of $10.45 billion to $10.75 billion. The new forecast assumes “modest” revenue from Aduhelm in 2021, ramping up thereafter, the company said. 2-Naphthalenepropanamine, 3-bromo-N-hydroxy-7-methoxy-N-methyl- suppliers Earlier this month, the drugmaker lifted a voluntary EU marketing hold on Zynteglo for beta thalassemia, after a patient death in one of the drugmaker’s other products, LentiGlobin, halted clinical studies. 5-(2-bromoprop-2-enyl)-1,3-benzodioxole vendor & factory.